EBITDA: Income before interest, taxes, depreciation and amortization.
Oragenics, Inc. (OGEN) had EBITDA of $-8.59M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-9.84M |
|
-- |
|
-- |
|
$9.36M |
|
$-9.36M |
|
$-0.62M |
|
$-9.98M |
|
$-9.98M |
|
$-9.84M |
|
$-9.84M |
|
$-9.84M |
|
$-9.84M |
|
$-9.36M |
|
|
EBITDA |
$-8.59M |
2.16M |
|
2.16M |
|
$-4.56 |
|
$-4.56 |
|
| Balance Sheet Financials | |
$10.07M |
|
-- |
|
-- |
|
$10.07M |
|
$1.79M |
|
-- |
|
-- |
|
$1.79M |
|
$8.28M |
|
$8.28M |
|
$8.28M |
|
4.27M |
|
| Cash Flow Statement Financials | |
$-9.25M |
|
-- |
|
$16.78M |
|
$0.86M |
|
$8.40M |
|
$7.53M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.64 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-118.85% |
|
-118.85% |
|
-97.76% |
|
-118.85% |
|
$1.94 |
|
$-4.29 |
|
$-4.29 |
|